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Background: The members of Toll-like receptor (TLR) family are responsible for
recognizing various molecular patterns associated with pathogens. Their expression is
not conﬁned to immune cells and have been detected in skin cells such as keratinocytes
and melanocytes. As part of a generated response to pathogens, TLRs are involved in
inducing inﬂammatory mediators to combat these threats. It is therefore not surprising
that TLRs have been implicated in inﬂammatory skin diseases, including atopic dermatitis
and psoriasis. Likewise, as key players in autoimmunity, they have been associated with
a number of autoimmune diseases. Based on this, the role of TLRs in vitiligo could be
suspected, but is yet to be clearly established.
Methods: In order to conduct a genetic association analysis, 30 SNPs were selected
from TLR1-TLR8 and TLR10 regions to be genotyped in Estonian case-control cohort
consisting of 139 vitiligo patients and 307 healthy control individuals. The patients
were further analyzed in subgroups based on sex, age of onset, occurrence of vitiligo
among relatives, extent of depigmented areas, vitiligo progression activity, appearance
of Köbner’s phenomenon, existence of halo naevi, and incidence of spontaneous
repigmentation.
Results: The most notable ﬁnding came with SNP rs179020 situated in TLR7 gene,
that was associated in entire vitiligo (Padj= 0.0065) and also several subgroup analyses.
Other single marker and haplotype analyses pointed to TLR3, TLR4, and TLR10 genes.
Conclusions: This study investigated the genetic regions of nine TLR genes in relation to
vitiligo susceptibility. The main results were the associations of TLR7 SNPs with vitiligo,
while several other associations were obtained from the remaining TLR gene regions.
This suggests that in addition to other inﬂammatory skin diseases, TLRs affect the
development of vitiligo, thus making them interesting targets for future research.
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Introduction
Vitiligo is a chronic disease manifested by distinctive lightening
of the skin and the cause to these depigmented areas
is in the loss of melanocytes. It is considered to be a
complex disease, as there is a multitude of genetic and
environmental factors involved in this process (Boissy and
Spritz, 2009). The precise set of contributors is yet to be
determined, but the general consensus approaches it as an
autoimmune disease (Le Poole and Luiten, 2008). This notion
is supported by the ﬁndings that vitligo susceptibilty genes
primarily include immune-related genes and by the frequent
co-occurrence with other autoimmune diseases (Spritz, 2011).
It also implies that a shared genetic background with diﬀerent
self-reactive pathologies can be expected. At the same time, the
importance of environmental risk factors remains, in that the
concordance in monozygotic twins is only 23% (Alkhateeb et al.,
2003).
Toll-like receptors (TLRs) function as critical components
of innate immune system by recognizing various molecular
motifs associated with pathogens or tissue injury (Takeda
et al., 2003). This leads to the induction of inﬂammatory and
antimicrobial innate immune responses as well as antigen-
speciﬁc adaptive immune mechanisms (Akira and Takeda,
2004). Crucial to this system is the discrimination between self
and foreign antigens and regulatory control over downstream
immune activation. The breakdown of these processes causes
autoimmunity and TLRs are suggested to have a pivotal function
in this pathology (Pradhan et al., 2012; Liu et al., 2014).
Indeed, they have been associated with various autoimmune
diseases and vitiligo among them (Kang et al., 2009; Yu et al.,
2009). Speciﬁcally, TLR3 that is expressed in melanocytes may
sense viral infection and induce apoptosis along with local
immune response, that contributes to vitiligo development (Yu
et al., 2009). TLR4 in melanocytes could react to endogenous
heat-shock proteins and initiate autoimmunity (Yu et al.,
2009). Activation of TLR7 may trigger melanocyte apoptosis
and thus the appearance of vitiligo symptoms (Kang et al.,
2009).
The expression of TLRs has been detected in keratinocytes,
melanocytes, and Langerhans cells of the skin (Hari et al.,
2010). As could be expected, they have been implicated
in a several inﬂammatory skin diseases such as atopic
dermatitis, psoriasis, and acne vulgaris (Miller, 2008; Hari
et al., 2010). On a genetic level, only a few studies have
been conducted, yielding support for TLR2 involvement
in atopic dermatitis (Oh et al., 2009) and TLR9 in
psoriasis treatment response (Romaní et al., 2015). Still, a
recent report has found TLR2 and TLR4 single-nucleotide
polymorphisms (SNPs) to be associated with vitiligo (Karaca
et al., 2013).
Considering this background, the aim of this study
was to explore possible genetic associations between TLR
gene polymorphisms and vitiligo. Thirty SNPs from six
genetic loci containing TLR1-TLR8 and TLR10 genes
were selected for genotyping and subsequent association
analyses.
Materials and Methods
Study Sample
To assemble the study sample, 139 vitiligo patients and 307
healthy control individuals were enrolled at the Department
of Dermatology, University of Tartu, Estonia. All subjects were
unrelated, of Caucasian origin, and living in Estonia. Vitiligo
diagnosis was based on characteristic skin depigmentation at
typical locations and whiteness of skin lesions under Wood’s
lamp. To conduct additional analyses, the patients were separated
into subgroups according to several characteristics. Female (n =
94) and male (n = 45) patients were analyzed independently
against their respective controls (n = 168; n = 139). Early onset
vitiligo (n = 41) was assigned in case the symptoms appeared
before the age of 20 and late onset (n = 98) in case 20 or
after. Familial vitiligo (n = 36) was determined by occurrence
of vitiligo in patients’ relatives and the absence of vitiligo among
them indicated the sporadic cases (n = 102). One patient fell in
neither category, since family data was not available. The extent
of aﬀected areas was the basis of next two groups: extent <
10% (n = 71) and extent ≥ 10% (n = 68). The patients were
classiﬁed to have active vitiligo (n = 96) in case new areas of
depigmentation had appeared during the previous 3 months and
stable vitiligo (n = 43) if new areas or enlargement of previously
existing depigmentation had not occurred during this period.
Patients with Köbner’s phenomenon, manifested by development
of new vitiligo patches at sites of skin injury, comprised the
Köbner positive group (n = 23). The occurrence of halo naevi
(n = 19) and spontaneous repigmentation (n = 38) were the
last distinguishing factors. The control group was recruited at
University of Tartu from medical students, health care personnel
and patients presenting at the dermatological outpatient clinic
with mild expression of either facial teleangiectasis or skin
tags.
The Human Research Ethics Committee of the University of
Tartu approved the study and informed consent was obtained
from all participants.
SNP Selection and Genotyping
SNPbrowser version 3.5 was used for SNP selection and for
SNPlex™ (Applied Biosystems) assay pool design. The SNPs were
located in six loci that contain the genes TLR1-TLR8 and TLR10
(Table 1). The SNPs were selected to evenly cover each locus and
non-synonymous SNPs were always preferred. Genomic DNA
was extracted from 9ml blood samples and Applied Biosystems
SNPlex™ method was used for genotyping (Tobler et al., 2005).
Data Analysis
The Haploview v4.2 program was used for Hardy-Weinberg
equilibrium (HWE) calculations in control group and also for
allelic association and haplotype association tests between groups
of patients and controls (Barrett et al., 2005). The Solid spine
of LD algorithm integrated in Haploview v4.2 was applied to
deﬁne the haplotype blocks and the resulting blocks were used in
the haplotype association test. Diﬀerences in allele or haplotype
frequencies between cases and controls were assessed by chi
square test. The statistical signiﬁcance threshold was set to 0.05
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TABLE 1 | Characteristics of studied SNPs.
SNP Chr region Base position Gene Minor/major alleles Function MAF
rs2247421 1q41 221406312 G/T 0.349
rs4140967 1q41 221418246 G/C 0.312
rs10776482 4p14 38451180 TLR10 C/T coding-synonymous 0.147
rs7694115 4p14 38455489 TLR10 G/A intron 0.382
rs7660429 4p14 38458876 TLR10 G/C intron 0.251
rs12233670 4p14 38463611 T/C 0.138
rs10005625 4p14 38471547 T/C 0.003
rs5743828 4p14 38503915 TLR6 A/G near-gene-3 (failed) 0.185
rs5743810 4p14 38506745 TLR6 T/C missense (Ser249Pro) 0.385
rs6531668 4p14 38509990 A/G 0.428
rs6531670 4p14 38511417 C/T 0.441
rs1992253 4q31.3 154822378 T/C 0.031
rs4585282 4q31.3 154832096 TLR2 T/C intron 0.01
rs7694512 4q31.3 154837310 TLR2 T/G intron 0.362
rs13123230 4q31.3 154840035 TLR2 G/A intron 0.388
rs1339 4q31.3 154851013 RNF175 G/A missense (Met195Ile) 0.261
rs2289318 4q31.3 154853184 RNF175 C/G intron 0.255
rs11721827 4q35.1 187228131 TLR3 C/A intron 0.198
rs6552950 4q35.1 187231850 TLR3 G/A intron 0.253
rs4608848 4q35.1 187247098 C/T 0.383
rs1519309 4q35.1 187252083 G/A 0.298
rs10759932 9q33.1 119504965 TLR4 C/T near-gene-5 0.196
rs5030728 9q33.1 119514103 TLR4 A/G intron 0.269
rs5935436 Xp22.2 12793812 TLR7 T/C near-gene-5 0.069
rs179020 Xp22.2 12799778 TLR7 T/C intron 0.26
rs179013 Xp22.2 12811392 TLR7 T/C intron 0.266
rs179008 Xp22.2 12813580 TLR7 T/A missense (Leu11Gln) 0.279
rs10127190 Xp22.2 12816916 TLR7 A/T UTR-3 0.004
rs850632 Xp22.2 12819487 C/T 0.264
rs179003 Xp22.2 12823862 G/T 0.196
MAF, minor allele frequency among vitiligo patients and healthy controls.
RNF175, ring ﬁnger protein 175.
for all tests. Ten thousand permutations were performed to
correct p-values for errors of multiple testing. SNPs of each of
the studied regions were analyzed separately.
Results
The genotyping procedure provided data for 30 SNPs and 29 of
them qualiﬁed for subsequent statistical analysis. A single SNP
rs5743828 was excluded due to deviation from Hardy-Weinberg
equilibrium. All the remaining markers met the inclusion criteria
for minor allele frequency (MAF > 1%) and Hardy-Weinberg
equilibrium (Hardy-Weinberg p > 0.01).
Allelic Association Analysis
Single marker associations were present in all studied regions
except for chromosome 1q41. Four associations were revealed
when analysing the entire vitiligo group and the rest were
produced when analysing by diﬀerent subgroups. The results
obtained from entire vitiligo, early onset, late onset, familial,
sporadic, extent < 10%, extent ≥ 10%, active, and stable vitiligo
analyses are presented in Table 2.
The SNPs of region 4p14 provided 10 associations. SNP
rs7694115 was associated in entire vitiligo group [p = 0.0446,
odds ratio (OR) 1.35, 95% conﬁdence interval (CI) 1.01–1.81]
and also in stable (p = 0.0226, OR 1.7, CI 1.07–2.69), male (p =
0.006, OR 1.96, CI 1.21–3.17), extent < 10% (p = 0.0214, OR
1.55, CI 1.06–2.24), and late onset (p = 0.0387, OR 1.42, CI 1.02–
1.97) subgroups. SNP rs10776482 was associated in extent≥ 10%
(p = 0.0134, OR 1.81, CI 1.13–2.9) and Köbner (p = 0.023, OR
2.28, CI 1.1–4.71) subgroups. SNP rs7660429 was associated in
extent < 10% (p = 0.0045, OR 1.77, CI 1.19–2.64), rs12233670
in male (p = 0.0095, OR 2.28, CI 1.21–4.29), and rs6531668 in
early onset (p = 0.0385, OR 1.63, CI 1.02–2.59) subgroups. The
association of rs7660429 in extent < 10% remained signiﬁcant
after correcting for multiple testing (p = 0.0469).
In 4q31.3 region, a single SNP rs4585282 was associated in
stable (p = 0.0264, OR 4.5, CI 1.05–19.17) and Köbner (p =
0.0162, OR 6.07, CI 1.14–32.27) subgroups.
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A single SNP rs6552950 of 4q35.1 region was associated in
male subgroup (p = 0.0213, OR 0.49, CI 0.27–0.91).
Next, a single SNP rs5030728 of 9q33.1 region was associated
in female (p = 0.0384, OR 0.62, CI 0.39–0.98), familial (p =
0.0077, OR 0.37, CI 0.17–0.79), and extent ≥ 10% (p = 0.0082,
OR 0.51, CI 0.3–0.84) subgroups. The last two associations
remained signiﬁcant after correcting for multiple testing (p =
0.0165 and p = 0.0227, respectively).
The most notable results occurred in Xp22.2 region and
concerned the SNP rs179020. It was associated in entire vitiligo
group (p = 8.5E-5, OR 1.95, CI 1.39–2.73) and also active
(p = 0.0027, OR 1.8, CI 1.22–2.64), stable (p = 0.0012, OR 2.36,
CI 1.39–4.03), female (p = 0.0483, OR 1.52, CI 1–2.31), male
(p = 8.8E-5, OR 3.1, CI 1.73–5.55), sporadic (p = 8.7E-5, OR
2.1, CI 1.44–3.06), extent < 10% (p = 0.0014, OR 1.99, CI 1.3–
3.06), extent ≥ 10% (p = 0.004, OR 1.91, CI 1.22–2.97), Köbner
(p = 0.0265, OR 2.3, CI 1.08–4.9), halo (p = 0.0056, OR 2.69,
CI 1.3–5.54), and late onset (p = 1.5E-6, OR 2.46, CI 1.69–3.56)
subgroups. The results in entire vitiligo, male, sporadic, and late
onset groups remained signiﬁcant after correcting for multiple
testing (p = 0.0065, p = 0.0479, p = 0.0078, and p = 0.0004,
respectively). In addition, two other SNPs on this region were
associated in entire vitiligo group. These were rs179013 (p =
0.0208, OR 1.45, CI 1.06–1.98) and rs179008 (p = 0.041, OR 1.39,
CI 1.01–1.9). The former was also associated in active (p = 0.019,
OR 1.52, CI 1.07–2.17), sporadic (p = 0.0326, OR 1.46, CI 1.03–
2.07) and late onset (p = 0.0291, OR 1.48, CI 1.04–2.1) vitiligo
subgroups and the latter in active vitiligo subgroup (p = 0.0293,
OR 1.48, CI 1.04–2.12). Finally, rs5935436 was associated with
vitiligo in females (p = 0.0102, OR 0.3, CI 0.11–0.79) and in
extent ≥ 10% group (p = 0.0192, OR 0.27, CI 0.08–0.87).
Haplotype Association Analysis
Haplotype blocks were formed by SNPs of all studied regions.
Similarly, to single marker analysis, haplotype associations were
revealed in all regions except for 1q41. Seven associations were
obtained in entire vitiligo group and others occurred in diﬀerent
vitiligo subgroups. The composition of haplotype blocks and
results of haplotype association analysis in entire vitiligo group
are presented in Table 3.
Haplotype AAC of 4p14 region that included alleles of
rs10776482, rs7694115, and rs7660429 was associated in entire
vitiligo group (p = 0.021, OR 0.71, CI 0.53–0.95) along with
stable (p = 0.0228, OR 0.59, CI 0.37–0.93), male (p = 0.0103,
OR 0.54, CI 0.33–0.87), extent < 10% (p = 0.019, OR 0.64,
CI 0.44–0.93), Köbner (p = 0.0427, OR 0.54, CI 0.3–0.99),
and late onset (p = 0.0149, OR 0.67, CI 0.48–0.93) subgroups.
Haplotype AGGof the same block was associated in extent< 10%
subgroup (p = 0.0031, OR 1.8, CI 1.22–2.67) and this remained
signiﬁcant after correcting for multiple testing (p = 0.0331).
The other block of this region was formed by rs12233670,
rs10005625, rs5743810, and rs6531668. Exception to this was
the male vitiligo analysis, where rs6531670 was also added to
this block and haplotype TCGGT provided the only association
(p = 0.021, OR 2.15, CI 1.11–4.16). The other exception in
block formation was the female vitiligo analysis where the ﬁrst
block included rs10776482, rs7694115, rs7660429, rs12233670,
and rs5743810, and the second block included rs6531668 and
rs6531670.
Two haplotype blocks were formed by SNPs of 4q31.3 region.
The ﬁrst block was usually composed of rs1992253, rs4585282,
rs7694512, and rs13123230 and the second block of rs1339 and
rs2289318. This was not the case in stable, extent< 10% and early
onset analyses, where the last SNP of block 1 rs13123230 was
transferred to block 2. Additionally, in familial vitiligo analysis
rs7694512 of block 1 was also transferred to block 2 and in male
vitiligo analysis the ﬁrst SNP of block 1 was omitted, leaving
rs4585282, rs7694512, and rs13123230 in that block. The only
haplotype associations found in this region came from block
1, where haplotypes CCG and CCT were associated with stable
vitiligo (p = 0.034, OR 0.61, CI 0.39–0.97 and p = 0.0217, OR
1.7, CI 1.07–2.68, respectively).
The SNPs of 4q35.1 region formed a single haplotype block.
It contained all four SNPs of this region, except for male vitiligo
analysis, where the last SNP rs1519309 was not included in the
block. The strongest associations were uncovered for haplotype
AACT in entire vitiligo group (p = 7.0E-4, OR 5.84, CI 1.85–
18.45) and in active (p = 1.0E-4, OR 7.22, CI 2.25–23.23), female
(p = 0.0018, OR 10.35, CI 1.7–63.1), sporadic (p = 0.0051,
OR 5.31, CI 1.44–19.67), extent = 10% (p = 8.0E-4, OR 7.5, CI
1.87–30.05), spontaneous repigmentation (p = 1.0E-4, OR 10.24,
CI 2.38–44.02) and late onset (p = 0.0018, OR 5.95, CI 1.69–
20.96) subgroups. Notably, all these seven associations remained
signiﬁcant after correcting for multiple testing (p = 0.0068, p =
0.0016, p = 0.0139, p = 0.0394, p = 0.0114, p = 0.0023, and
p = 0.0203, respectively). Haplotype AGCT was associated in
familial (p = 0.0092, OR 4.3, CI 1.29–14.35), Köbner (p = 9.0E-
4, OR 6.13, CI 1.82–20.57) and early onset (p = 0.0306, OR 3.52,
CI 1.04–11.9) subgroups. The result in Köbner group remained
signiﬁcant after correcting for multiple testing (p = 0.0141).
Haplotypes AAT and AGT were associated with vitiligo in males
(p = 0.0225, OR 1.75, CI 1.08–2.83 and p = 0.0286, OR 0.51, CI
0.27–0.94, respectively).
The two SNPs of 9q33.1 region formed a haplotype block in
each of the analyzed groups. Haplotype TA was associated in
female (p = 0.0401, OR 0.63, CI 0.4–0.98), familial (p = 0.0098,
OR 0.39, CI 0.19–0.82) and extent ≥ 10% (p = 0.0086, OR
0.51, CI 0.3–0.85) subgroups. The last two associations remained
signiﬁcant after correcting for multiple testing (p = 0.0198 and
p = 0.0234, respectively).
Depending on the analyzed group, two or three haplotype
blocks were formed by SNPs of Xp22.2 region. Three blocks
were present in entire vitiligo group, and active, male, sporadic,
extent < 10% and late onset subgroups. Block 1 included
rs5935436 and rs179020, block 2 included rs179013 and
rs179008, and block 3 included the remaining rs10127190,
rs850632 and rs179003. The strongest associations involved block
1 haplotype CA in entire vitiligo (p = 5.0E-4, OR 1.75, CI 1.28–
2.4), active (p = 0.0109, OR 1.59, CI 1.11–2.29), male (p =
0.0026, OR 2.23, CI 1.31–3.79), sporadic (p = 8.0E-4, OR 1.81,
CI 1.28–2.57), extent < 10% (p = 0.0094, OR 1.7, CI 1.13–2.54),
and late onset (p = 2.6E-5, OR 2.1, CI 1.48–2.98) vitiligo groups.
From these, the associations in entire vitiligo, sporadic, and late
onset vitiligo groups remained signiﬁcant after correcting for
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TABLE 3 | Results of haplotype analysis in entire vitiligo group.
Chr region Block Haplotype Freq case Freq control P-value
1q41 Block 1 rs2247421 rs4140967
A C 0.662 0.644 0.6107
C G 0.298 0.316 0.5817
C C 0.040 0.038 0.8593
4p14 Block 1 rs10776482 rs7694115 rs7660429
A A C 0.547 0.628 0.021
A G G 0.285 0.235 0.1147
G G C 0.146 0.127 0.4271
G A C 0.019 0.009 0.2357
Block 2 rs12233670 rs10005625 rs5743810 rs6531668
C C G G 0.431 0.447 0.6687
C C A A 0.376 0.382 0.8634
T C G G 0.144 0.124 0.4179
C C G A 0.040 0.040 0.9875
4q31.3 Block 1 rs1992253 rs4585282 rs7694512 rs13123230
C C G A 0.604 0.599 0.8859
C C T G 0.346 0.322 0.4869
C C G G 0.022 0.035 0.3251
T C T G 0.013 0.034 0.0748
Block 2 rs1339 rs2289318
T G 0.494 0.490 0.9195
C G 0.249 0.257 0.8088
T C 0.251 0.249 0.9398
4q35.1 Block 1 rs11721827 rs6552950 rs4608848 rs1519309
A A T T 0.248 0.253 0.8802
A G T T 0.195 0.233 0.2055
C A C T 0.192 0.171 0.4556
A A C C 0.143 0.166 0.3951
A A T C 0.133 0.116 0.4745
A G C T 0.026 0.013 0.1655
A A C T 0.038 0.007 7.0E-4*
C A T T 0.012 0.015 0.6581
9q33.1 Block 1 rs10759932 rs5030728
T G 0.575 0.517 0.1331
T A 0.223 0.287 0.0596
C G 0.203 0.196 0.8298
Xp22.2 Block 1 rs5935436 rs179020
C G 0.619 0.699 0.0187
C A 0.333 0.222 5.0E-4*
T G 0.039 0.076 0.0402
Block 2 rs179013 rs179008
G A 0.672 0.741 0.034
A T 0.313 0.242 0.0275
G T 0.011 0.015 0.6794
Block 3 rs10127190 rs850632 rs179003
T A T 0.588 0.601 0.7061
T G T 0.200 0.207 0.8161
T A G 0.145 0.135 0.6818
T G G 0.064 0.052 0.4991
P ≤ 0.05 bolded.
* P ≤ 0.05 after 10 000 permutations.
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multiple testing (p = 0.0244, p = 0.04, p = 0.0035, respectively).
Haplotype CG of the same block was associated in entire vitiligo
(p = 0.0187, OR 0.7, CI 0.52–0.94), male (p = 0.0018, OR
0.45, CI 0.28–0.75), sporadic (p = 0.025, OR 0.68, CI 0.49–0.95),
extent < 10% (p = 0.0246, OR 0.65, CI 0.44–0.95) and late onset
(p = 0.0028, OR 0.6, CI 0.43–0.84) vitiligo groups. The third
haplotype of this block TG was associated with entire vitligo (p =
0.0402, OR 0.5, CI 0.25–0.98) as well as sporadic (p = 0.035, OR
0.42, CI 0.18–0.97) and late onset vitiligo (p = 0.0246, OR 0.38,
CI 0.16–0.91). Block 2 haplotypes gave more modest associations
when haplotype GA was associated in entire vitiligo (p = 0.034,
OR 0.72, CI 0.53–0.98) and active vitiligo (p = 0.0214, OR
0.66, CI 0.47–0.94) groups and haplotype AT in entire vitiligo
(p = 0.0275, OR 1.42, CI 1.04–1.95), active (p = 0.0272, OR
1.49, CI 1.05–2.12), sporadic (p = 0.0449, OR 1.43, CI 1.01–
2.02) and late onset (p = 0.0408, OR 1.45, CI 1.02–2.06) vitiligo
groups. In seven subgroups, namely stable, familial, extent ≥
10%, Köbner, halo naevi, spontaneous repigmentation and early
onset vitiligo the ﬁrst two haplotype blocks were combined into a
single haplotype block containing four SNPs. Haplotype CAAT of
this extended block was associated in stable (p = 5.0E-4, OR 6.15,
CI 1.95–19.46), familial (p = 0.0212, OR 4.54, CI 1.13–18.31),
and early onset (p = 0.0029, OR 5.01, CI 1.56–16.15) subgroups.
Haplotypes CGGA and CAGA were both associated in extent ≥
10% (p = 0.034, OR 0.66, CI 0.45–0.97 and p = 0.0388, OR 1.55,
CI 1.02–2.35, respectively) and halo naevi (p = 0.0191, OR 0.42,
CI 0.2–0.89 and p = 0.012, OR 2.34, CI 1.18–4.62, respectively)
subgroups and haplotype TGGA only in extent ≥ 10% subgroup
(p = 0.0374, OR 0.3, CI 0.09–0.99). One additional version of
this ﬁrst haplotype block was present in female vitiligo analysis.
In this instance, SNP rs10127190 was also added to the extended
haplotype block and thus it contained ﬁve SNPs. Haplotypes
TGGAT (p = 0.0085, OR 0.26, CI 0.09–0.76) and CAATT (p =
0.0302, OR 3.26, CI 1.06–10.01) were both associated with vitiligo
in females.
Discussion
The genotyping procedure in Estonian case-control sample
provided data for 29 SNPs. Four allelic and seven haplotype
associations were revealed when analysing the entire vitiligo
group. In addition, 31 allelic and 48 haplotype associations were
present in diﬀerent subgroups. In terms of genetic location,
results with various strength were obtained from all studied
regions, except for 1q41 that contains TLR5 gene.
The most notable SNP in 4p14 region was rs7694115. It was
associated in entire vitiligo analysis as well as four subgroup
analyses. The given marker is situated in the intron of TLR10
gene. Two other SNPs of TLR10 (rs10776482 and rs7660429)
and one SNP located in 5′ direction from TLR10 (rs12233670)
were associated in vitiligo subgroups. Of note, rs7660429 and
haplotype AGG (rs10776482A, rs7694115G, and rs7660429G)
produced a strong association speciﬁcally in extent < 10%
group, that survived the adjustment for multiple testing. TLR10
protein is expressed by B cells, plasmacytoid dendritic cells and
regulatory T cells, but the speciﬁc function remains to be clariﬁed
since the identity of its ligand has not been established (Hasan
et al., 2005; Bell et al., 2007). Previous genetic studies have
associated TLR10 with inﬂammatory diseases such as asthma
(Lazarus et al., 2004), Crohn’s disease (Abad et al., 2011; Morgan
et al., 2012) and Ménière’s disease, that is suspected to have
autoimmune properties (Requena et al., 2013). Interestingly,
associated SNPs of all these studies fall in the range of here
described haplotype block 1 consisting of rs10776482, rs7694115,
and rs7660429. It is therefore plausible, that the presently
associated SNPs are in linkage disequilibrium with variants
that cause changes in TLR10 function and eventually aﬀect
disease outcome. There was still another SNP rs6531668 in
4p14 region that was associated in a single subgroup. It is
positioned in TLR6 gene, that has been associated with asthma
(Tantisira et al., 2004) and coronary artery disease (Hamann et al.,
2013).
One SNP from 4q31.3 region displayed modest associations
in vitiligo subgroups. That was rs4585282 located in intron 2 of
TLR2 gene. The respective protein TLR2 recognizes a wide array
of antigens and has been suggested to play an instrumental role
in the development of self-reactive diseases (Borrello et al., 2011).
In the skin, TLR2 is expressed in antigen-presenting Langerhans
cells, as well as keratinocytes and melanocytes (Yu et al., 2009;
Hari et al., 2010). Polymorphisms in this gene have been
associated with autoimmune diseases, namely type 1 diabetes,
allergic asthma (Bjornvold et al., 2009), severe ulcerative colitis
(Pierik et al., 2006) and also atopic dermatitis, that is proposed to
hold autoimmune qualities (Ahmad-Nejad et al., 2004; Cipriani
et al., 2014). More intriguingly, the Arg753Gln (rs5743708)
polymorphism was associated with vitiligo in Turkish patients
(Karaca et al., 2013). It is located 14 kb from the currently
associated rs4585282 and is a missense mutation causing arginine
to glutamine substitution in TLR2 peptide. The haplotype block
1 that contains rs4585282 did not reach over the position of
Arg753Gln and the possible relationship between these two
polymorphisms together with eﬀects on TLR2 activity remain to
be determined.
The four SNPs of 4q35.1 were in the region of TLR3 gene.
SNP rs6552950 from TLR3 intron produced the only allelic
association with vitiligo among males. However, several strong
haplotype associations appeared in entire vitiligo and subgroup
analyses, that remained statistically signiﬁcant after correcting for
multiple testing. The TLR3 receptor recognizes double-stranded
(ds)RNA during viral infection and initiates the production of
type I interferons in response. It has been shown that TLR3
is also expressed in melanocytes and stimulation with dsRNA
leads to apoptosis (Yu et al., 2011). To date, polymorphisms of
TLR3 have been associated with several chronic inﬂammatory
diseases e.g., rheumatoid arthritis (Laska et al., 2014a), systemic
lupus erythematosus (SLE) (Laska et al., 2014b) and osteoarthritis
(Yang et al., 2013), the ﬁrst two of which are autoimmune
diseases. Interestingly, the associated polymorphisms in these
reports (rs3775296, rs5743312, rs3775291, and rs3775290) fall in
the range of a haplotype block formed by the SNPs genotyped
in this study. Therefore, it is possible that these associations
signal the existence of certain causal polymorphisms within the
block, such as the non-synonymous rs3775291, that aﬀect vitiligo
pathology.
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A single SNP rs5030728 from 9q33.1 region was associated in
familial, extent≥ 10% and female subgroups. Likewise, haplotype
TA consisting of rs10759932T and rs5030728A was associated
in the same groups. Notably, the results from familial and
extent ≥ 10% groups remained signiﬁcant when corrections for
multiple testing were applied. The former SNP is located near
the 5′ end of TLR4 gene and the latter is an intronic SNP of
TLR4. This receptor is known for recognizing lipopolysaccharide
from gram-negative bacteria, which induces the production of
proinﬂammatory cytokines and Type I interferons (Lu et al.,
2008). As a contributor to TLR2/TLR4 pathway, it has been
attributed a pivotal function in the pathogenesis of autoimmune
diseases (Liu et al., 2014). Similarly, to TLR2 and TLR3, it has
been detected in Langerhans cells, keratinocytes andmelanocytes
(Hari et al., 2010). Polymorphisms of TLR4 have been associated
with Crohn’s disease, ulcerative colitis (Shen et al., 2010b),
asthma (Zhang et al., 2011) and atherosclerosis (Kiechl et al.,
2002). Remarkably, the Asp299Gly (rs4986790) polymorphism
was also associated with vitiligo among Turkish patients (Karaca
et al., 2013). It is positioned 1 kb from rs5030728 and while not
situated within here described haplotype block, it may still be in
linkage disequilibrium with these SNPs. Hence, it is possible that
the current associations with non-coding SNPs reﬂect the eﬀect
of missense Asp299Gly on TLR2 activity. Conversely, they may
have an independent impact and rs5030728 has been suggested
to play a role in metabolic syndrome (Cuda et al., 2011) and
inﬂammatory bowel disease treatment response (Bank et al.,
2014). The other contributor to TA haplotype described above,
rs10759932, has been associated with prostate cancer (Cheng
et al., 2007), chorionic plate inﬂammation (Simhan et al., 2008)
and atopy (Penders et al., 2010).
The ﬁnal studied region was in Xp22.2 that contained TLR7
and TLR8 genes. The strongest associations were obtained
with SNP rs179020 located in intron 2 of TLR7. Notably, this
SNP remained signiﬁcant after correcting for multiple testing
in entire vitiligo and three subgroup analyses: male, sporadic,
and late onset vitiligo. Furthermore, allele rs5935436C together
with rs179020A formed a haplotype CA, that withstood the
correction in all these groups except vitiligo males. Three other
SNPs from TLR7 region—rs5935436, rs179013, and rs179008—
produced weaker allelic associations in entire vitiligo and
subgroup analyses. TLR7 is an intracellular receptor located in
endosomes, that binds single-stranded RNA and induces the
production of inﬂammatoty cytokines (Diebold et al., 2004). In
addition to immune cells, its expression has been demonstrated
in melanocytes (Kang et al., 2009). It is intriguing to note,
that topical administration of TLR7 agonist imiquimod has
been shown to be associated with vitiligo-like hypopigmentation
(Brown et al., 2005). Considering that TLR7 activation may
lead to apoptosis (Meyer et al., 2003), this eﬀect could be
due to TLR7 induced loss of melanocytes. Concurrently,
the role of TLR7 in other autoimmune diseases has been
widely reported, especially in the case of SLE (Deane et al.,
2007; O’Neill et al., 2009). The proposed mechanism involves
activation of autoreactive B cells through TLR7 signaling, while
TLR9 acts as a restrictor of this process and the role of
TLR8 is yet to be clariﬁed (Soni et al., 2014). On a genetic
level, TLR7 SNPs have been associated with Graves’ disease
(Xiao et al., 2015) and SLE (Shen et al., 2010a; Enevold
et al., 2014). Among the four SNPs associated in this study,
rs179008 has recently been associated with asthma (Møller-
Larsen et al., 2008), multiple sclerosis (Enevold et al., 2010),
and SLE (dos Santos et al., 2012). It is a non-synonymous
mutation, where A to T substitution causes glycine to leucine
change in TLR7 peptide (Gln11Leu). Currently, T was the
associated allele, whereas previously both A and T were shown
to confer disease susceptibility (Møller-Larsen et al., 2008; dos
Santos et al., 2012). In silico analyses by Møller-Larsen and
colleagues suggested, that changing Gln11 to Leu shortens the
N-region and extends the H-region of TLR7 signal peptide,
thus potentially aﬀecting post-translational processing (Møller-
Larsen et al., 2008). Taken together, these genetic associations of
four TLR7 SNPs could indicate alterations in TLR7 functioning,
but the precise mechanisms remain to be determined in future
studies.
In conclusion, the present study revealed a number of genetic
associations between TLR gene SNPs and vitiligo susceptibility.
The main ﬁndings emerged with TLR7 SNP 179020 and TLR3
haplotype AACT. SNPs of TLR10 and TLR4 were associated
in speciﬁc subgroups, indicating their possible role in certain
subphenotypes. However, the interpretation of these results
should account for the small sample used, while the functional
eﬀects of studied SNPs remain to be elucidated in future
experiments.
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